[Uremic encephalopathy, dialysis encephalopathy].
Kinugasa
Eriko
E
Department of Internal Medicine, Showa University Northern Yokohama Hospital.
D000535:Aluminum / Q000009:adverse effects*; D001928:Brain Diseases, Metabolic / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D003676:Deferoxamine / Q000008:administration & dosage; D003937:Diagnosis, Differential; D006440:Hemofiltration; D006801:Humans; D007502:Iron Chelating Agents / Q000008:administration & dosage; D006435:Renal Dialysis / Q000009:adverse effects*; D014511:Uremia / Q000150:complications*
D007502:Iron Chelating Agents; D000535:Aluminum; D003676:Deferoxamine